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Interstitial leucocyte infiltration, a prominent feature of lupus
nephritis, predicts deterioration of renal function. We used
two models of lupus nephritis in mice, one with chronic
spontaneous disease and the other with acute interferon-a
(IFNa)-mediated disease. The latter is characterized by the
virtual absence of interstitial infiltration. In vivo migration
assays showed that splenic leukocytes from spontaneously
nephritic mice tended to migrate into non-inflamed
syngeneic kidneys. This was enhanced if the recipient kidneys
were already inflamed. Kidneys from both chronically and
acutely nephritic mice showed similar ability to recruit splenic
leukocytes from chronically diseased mice. Leukocytes from
acutely diseased mice, however, failed to migrate into
chronically inflamed kidney. Compared with those with
chronic nephritis, the kidneys of acute nephritic mice
expressed less of the inflammatory chemokine CXCL13/BLC.
Moreover, leukocytes from acute nephritic mice displayed
impaired migration, in vitro, to T-cell chemokine attractants.
This study links leukocyte infiltration to both kidney
chemokine expression, and leukocyte chemotaxis to kidney-
expressed chemokines.
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Lupus nephritis represents a major cause of morbidity and
mortality in systemic lupus erythematosus (SLE), and is
characterized by extreme diversity of pathological manifesta-
tions. Histologically, a spectrum of glomerular lesions occurs,
ranging from no or mild mesangial proliferation to full-
blown proliferative and crescentic glomerulonephritis.1
Along with glomerular lesions, inflammatory infiltrates are
frequently observed in the interstitium of SLE patient
kidneys.2,3 The severity of interstitial inflammation correlates
with the degree of renal damage,4,5 and it predicts
progression to renal insufficiency.6–9 Inflammatory interstitial
infiltrates in SLE nephritis are predominantly composed of
T and B lymphocytes and macrophages.2,10–12 They may
contribute through cytokine/chemokine release to the kidney
lesions observed in SLE.13 In animal models of lupus that
develop a disease close to human SLE and die of end-stage
renal failure,14 lupus nephritis is characterized, as in human
SLE, by variable degrees of glomerular and tubulointerstitial
inflammation comprised of mononuclear cells (ie, T, B,
lymphocytes, plasma cells, and macrophages).15–17
The mechanisms that underlie the accumulation of
leukocytes in the interstitium of the kidney of SLE patients
or of lupus mice remain to be defined. In particular, whether
leukocytes and/or kidney have particular properties that
favor such migration is an important question for a better
understanding of lupus nephritis pathogeny. To address this
issue, we compared renal alterations and leukocyte migration
to the kidney in a chronic model of lupus nephritis (ie,
unmanipulated NZBNZWF1 (NZB/W) mice) and in an
acute model of disease (ie, young NZB/W mice treated in vivo
with interferon-a (IFNa)).18,19 Our data show that acute
nephritis differs from chronic nephritis by the virtual absence
of interstitial leukocyte infiltration. Adoptive transfer experi-
ments and characterization of a series of chemokines at the
kidney and leukocyte levels reveal differences in both renal
chemokine expression and chemotaxis of spleen leukocytes to
kidney-expressed chemokines between the two models of
lupus nephritis. Thus, leukocyte interstitial infiltration in
lupus nephritis (or its absence) is linked to coordinated
action of both kidney chemokine expression and leukocyte
chemotaxis to kidney-expressed chemokines.
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RESULTS
Mechanism of leukocyte recruitment to the kidneys in lupus
nephritis
Renal histological examination of spontaneously nephritic
NZB/W mice showed a severe diffuse glomerulonephritis
with either segmental or global involvement of all glomeruli
(Figure 1c and d). Importantly, large perivascular interstitial
infiltrates were present (Figure 2, left panel). On immuno-
histochemical assessment, these inflammatory infiltrates
(Figure 3a and b) were found to be composed of B60% of
B cells (Figure 3d and e),B30% of T cells (Figure 3g and h),
and of o10% of myeloid cells (Figure 3j and k).
To test whether accumulation of leukocytes in kidneys
from mice with chronic lupus nephritis was due to active
recruitment from the circulation, we performed transfer
experiments with fluorescently labeled spleen leukocytes.
Leukocytes from spontaneously nephritic NZB/W donors
were labeled and transferred into nephritic NZB/W recipi-
ents. Parallel experiments were performed with Balb/c mice.
The numbers of labeled cells detected in the kidneys of NZB/
W recipient mice were significantly higher than those
detected in the kidneys of Balb/c mice (Table 1). This
increased recruitment involved both B (CD19þ ) and T
(CD3þ ) lymphocytes as well as myeloid (Mac1þ ) cells.
Role of leukocytes vs kidney in leukocyte recruitment
To determine the respective contribution of leukocytes vs
inflamed kidneys in the increased recruitment of circulating
leukocytes, we injected fluorescently labeled spleen leukocytes
from young or spontaneously nephritic NZB/W to either
young or diseased NZB/W mice. Parallel experiments
were performed with Balb/c mice. In all combinations
tested, leukocyte recruitment was minimal in Balb/c mice
(Figure 4a, c, e). When leukocytes from spontaneously
nephritic NZB/W were injected to young NZB/W mice, cell
recruitment was slightly but not significantly increased as
compared with controls (ie, ‘young’ donor cells to ‘young’
recipient kidney). Conversely, migration of leukocytes from
young NZB/W to kidneys of spontaneously nephritic NZB/W
mice was moderately but not significantly increased as
compared with controls. Strikingly, leukocytes from diseased
NZB/W showed significant migration into the kidneys of
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Figure 1 | Histological comparison of kidneys from ‘chronic’ and
IFNa-induced ‘acute’, nephritic NZB/W mice. Views of the kidney
(hematoxylin stained) of a spontaneously nephritic NZB/W mouse
(c, d); comparison with the kidney of a 4-week-old NZB/W mouse
(a, b). Views of the kidney of a nephritic, IFNa-treated NZB/W mouse
(g, h); comparison with the kidney of a NZB/W mouse treated with
the control Adv (e, f).
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Figure 2 | Histological comparison of interstitial infiltration
in kidneys from ‘chronic’ and IFNa-induced ‘acute’, nephritic
NZB/W mice. (a, c, e) Views of perivascular interstitial infiltrates in the
kidney (hematoxylin stained) of three individual spontaneously
nephritic NZB/W mice ; (b, d, f) view of the renal interstitium of three
individual, nephritic, IFNa-treated NZB/W mice. Note the large
perivascular infiltrates in the kidney of spontaneously nephritic
NZB/W mice (arrows) (c) compared with the virtual absence of these
infiltrates in IFNa-treated NZB/W mice (b, d, f).
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diseased NZB/W mice (Figure 4b, d, f). Both B and T
lymphocytes and myeloid cells from diseased NZB/W
exhibited a migration capacity B2- to 3-fold higher in
diseased recipient mice than in young mice. These fluorescent
leukocytes were visualized mainly in interstitial areas
(Figure 5). Of note, the prevalence of the original populations
of B cells, T cells, and myeloid cells within transferred spleen
cells was similar between young and spontaneously nephritic
NZB/W mice (Table 2). Thus, both leukocyte and kidney
abnormalities synergistically contribute to the increased
recruitment of circulating leukocytes in NZB/W mice with
lupus nephritis.
Normal migration of NZB/W leukocytes to lymphoid organs
We tested the ability of leukocytes from NZB/W mice with
lupus nephritis to migrate to organs other than the kidney
(ie, to lymphoid organs). Migration of leukocytes from
control Balb/c mice was studied in parallel. As shown in
Table 3 (where findings for B lymphocytes are reported), high
numbers of leukocytes migrated to lymphoid organs, both in
controls and in NZB/W mice. Nevertheless, migration of B
lymphocytes from either young or diseased NZB/W mice into
the lymphoid organs of diseased recipients did not differ
from that observed in Balb/c mice. Similar findings were
observed for T lymphocytes and myeloid cells (data not
shown). Thus, the increased ability of leukocytes from
nephritic NZB/W mice to migrate to tissues is restricted to
the kidney.
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Figure 3 | Immunohistochemical comparison of interstitial infiltration in kidneys from ‘chronic’ and IFNa-induced ‘acute’, nephritic
NZB/W mice. Hematoxylin stained views of perivascular infiltrates in the kidney of 2 individual spontaneously nephritic NZB/W mice
(a, b) and one nephritic, IFNa-treated mouse (c). Immunohistochemical staining of kidney sections from two individual spontaneously
nephritic NZB/W mice, and one IFNa-treated, nephritic mouse, stained for B lymphocytes (d–f), T lymphocytes (g–i), and myeloid cells (j–l).
Table 1 | Migration of circulating leukocytes in lupus nephritis
Balb/c NZB/W
CD19+ 873 34711*
CD3+ 1174 50712*
Mac-1+ 0 2473*
NZB/W, New Zealand Black/White.
Fluorescently labeled spleen cells from 7- to 9-month-old Balb/c or NZB/W mice
were injected to 7- to 9-month-old Balb/c or NZB/W mice, respectively. The numbers
of fluorescently labeled CD19+, CD3+, and Mac1+ cells per 106 lymphocytes in
recipient kidneys were assessed by flow cytometry. Results are expressed as the
mean7s.e.m., and are from eight independent experiments.
*Po0.05, Mann–Whitney U-test.
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Lack of interstitial infiltrates in kidneys from nephritic IFNa-
treated NZB/W mice
We recently developed an experimental model of lupus in
which systemic IFNa in vivo induces rapid and lethal lupus
nephritis in young NZB/W, but not in Balb/c, mice.18 We
therefore assessed the nature of kidney lesions in proteinuric,
IFNa-treated mice. As in the spontaneous model, histological
staining revealed a severe diffuse proliferative glomerulone-
phritis with either segmental or global involvement of all
glomeruli (Figure 1g and h). Wire loop lesions and segmental
glomerulosclerosis could also be identified. However, at
variance with the spontaneous model, there were very little
infiltrating leukocytes in the interstitium (Figure 2b, d, f),
which appeared to be predominantly T cells (vs B cells in the
chronic model) (compare panels f and i in Figure 3 with
panels d, e, g, h). Of note, nephritic IFNa-treated mice
showed a significant number of myeloid cells scattered all
over the renal interstitium (Figure 3l).
Leukocytes from nephritic IFNa-treated NZB/W do not
migrate to inflamed lupus kidneys
We asked whether IFNa treatment of NZB/W mice modified
the homing properties of their spleen leukocytes, which
might account for the absence of leukocyte infiltration in the
renal interstitium. Fluorescently labeled leukocytes from
nephritic IFNa-treated mice were injected in spontaneously
nephritic NZB/W recipients. Leukocytes from NZB/W mice
treated with a control adenovirus (Adv) were studied in
parallel. The prevalence of the original populations of B cells,
T cells, and myeloid cells within the transferred spleen cells
was similar between control Adv-treated and IFNa Adv-
treated, NZB/W mice (Table 2). Lymphocytes from IFNa-
treated mice did not migrate to the kidney of nephritic NZB/W
mice (Table 4). There was also no increased migration of
myeloid cells as compared with controls. Thus, IFNa
treatment of young NZB/W mice although triggering acute
and lethal lupus nephritis, does not increase the potency of
leukocytes to migrate to inflamed kidneys.
Conversely, we tested whether the kidney from nephritic
IFNa-treated mice attracts leukocytes from spontaneously
nephritic NZB/W mice. The kidney from IFNa-treated mice
had a capacity similar to that of spontaneously diseased NZB/
W mice to attract leukocytes from the latter (Figure 6a
and b). The frequency of B and T lymphocytes as well as that
of myeloid cells (Figure 6c) that migrated to the kidney was
similar when comparing kidneys from the ‘acute’ and the
‘chronic’ model of lupus nephritis.
Leukocytes from IFNa-treated and spontaneously nephritic
NZB/W mice display similar levels of activation
To test whether the inability of leukocytes from IFNa-treated
mice to migrate into the inflamed kidney reflected impaired
activation of ‘IFNa’ leukocytes, we compared the levels of
spleen leukocyte activation markers in the ‘chronic’ and
‘acute’ models of disease. T cells from IFNa-treated mice
displayed similar (or even higher) levels of the T lymphocyte
CD25 and CD69 activation markers than those from
spontaneously nephritic NZB/W (Figure 7a). Likewise,
CD86 levels on B cells as well as the frequency of
CD19þCD138þ plasma cells were comparable between
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Figure 4 | Role of leukocyte and kidney abnormalities in
leukocyte recruitment in lupus nephritis. Spleen cells from young
(7–10 weeks) or aged (7–9 months) normal mice (a–e) or nephritic
mice (b–f) were labeled and injected to either young or aged,
syngeneic mice, respectively. Migration of B lymphocytes (CD19þ
cells), (a, b) T lymphocytes (CD3þ cells) (c, d), and myeloid cells
(CD11bþ cells) (e, f) was analyzed 18 h later by flow cytometry.
Results are the mean7s.e.m. of labeled cells per 106 lymphoid cells in
the recipient kidneys, and are from eight independent experiments.
×10
Figure 5 | Migration of leukocytes in kidneys from spontaneously
nephritic NZB/W mice. Spontaneously nephritic NZB/W mice were
injected intravenously with syngeneic leukocytes from nephritic
mice, and were killed 18 h after injection. Kidney sections were
stained with DAPI (blue) and observed for the presence of fluorescent
migrated cells (pink). Note that the fluorescent cells are mainly
located in the interstitium.
Kidney International (2008) 73, 172–180 175
L Adalid-Peralta et al.: Lupus leukocyte migration into nephritic kidneys o r i g i n a l a r t i c l e
the two models (Figure 7b). Thus, the lack of significant
‘IFNa’ leukocyte infiltration is not explained by impaired
leukocyte activation.
Differential expression of chemokines in the kidneys of IFNa-
treated and unmanipulated NZB/W mice
Since chemokines are involved in the recruitment of
circulating leukocytes into the kidney,20,21 we asked whether
differential expression of renal chemokines could account for
the differential leukocyte recruitment seen between the two
models of lupus nephritis. Reverse transcription-polymerase
Table 2 | Composition of lymphoid and myeloid cells in spleens of donor mice
Numbers of cells/106 total number of spleen cells
Donor B cells T cells Myeloid cells
Young BALB/c (n=5) 371 354724 127 418 487731 543 50 28977289
Aged BALB/c (n=5) 403 229738 525 389 290734 011 46 01777783
Young NZB/W (n=5) 414 076715 691 372 572737 044 39 050712 569
Aged NZB/W (n=8) 438 380725 362 327 211739 597 47 36774170
Null Adv NZB/W (n=3) 453 910716 356 399 804741 736 39 40273656
IFNa Adv NZB/W (n=3) 442 434727 437 347 191718 962 66 748720 718
Adv, adenovirus; IFNa, interferon-a; NZB/W, New Zealand Black/White.
The respective cell representation of B, T, lymphocyte and myeloid cells among splenocytes from donor mice was determined. Results are expressed as the mean cell
number7s.d. of a given population per 106 total spleen cells.
P40.34 for all comparisons.
Table 3 | Homing of B lymphocytes to lymphoid organs
Labeled CD19+ cells (n/106 cells)
Recipient mice Young donor Aged donor
BALB/c
Spleen 42977486 514271203
Bone marrow 408762 5287128
Lymph nodes 8297242 7657429
NZB/W
Spleen 25087503 35837757
Bone marrow 4397108 391771
Lymph nodes 4717138 7037259
NZB/W, New Zealand Black/White.
Spleen cells from young or aged mice were fluorescently labeled and injected to
syngeneic, aged mice. Migration of fluorescently labeled B lymphocytes (CD19+
cells) to lymphoid organs was analyzed by flow cytometry. Results are expressed as
the mean7s.e.m. of labeled CD19+ cells per 106 lymphocytes of the recipient organ,
and are from eight independent experiments.
P40.1 for all comparisons.
Table 4 | Migration to kidneys of leukocytes from IFNa-
treated NZB/W mice
Adv-Null NZB/W Adv-IFNa NZB/W
CD19+ 1172 572
CD3+ 3378 2674
Mac-1+ 774 773
Adv, adenovirus; IFNa, interferon-a; NZB/W, New Zealand Black/White.
Fluorescently labeled spleen cells from NZB/W mice treated with either a control or
an mIFNa-encoding Adv were injected to aged NZB/W mice. The numbers of
fluorescently labeled CD19+, CD3+, and Mac1+ cells per 106 lymphocytes in
recipient kidneys were assessed by flow cytometry. Results are expressed as the
mean7s.e.m., and are from six mice in each group.
P40.1 for all comparisons.
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Figure 6 | Leukocyte recruitment in kidneys from IFNa-induced
lupus. Spleen cells from spontaneously nephritic, aged, NZB/W mice
were fluorescently labeled and injected to NZB/W recipients treated
with control Adv or IFNa Adv, or to spontaneously nephritic mice.
Migration of B lymphocytes (CD19þ cells) (a), T lymphocytes (CD3þ
cells) (b), and myeloid cells (CD11bþ cells) (c) was analyzed 18 h later
by flow cytometry. Results are expressed as the mean7s.e.m. of
labeled cells per 106 lymphoid cells in recipient kidneys, and are from
six mice in each group.
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Figure 7 | Leukocytes from both spontaneously and IFNa-treated,
nephritic NZB/W mice are activated. Spleen cells from nephritic,
aged, NZB/W mice and from their respective controls (untreated or
control Adv-treated, pre-autoimmune, mice) were phenotyped for
surface activation markers using CD25, and CD69 for CD3þ T cells
(a), and CD86 and CD138 for CD19þ B cells (b), respectively. Results
are expressed as the mean %7s.e.m. of activated cells vs total spleen
lymphocytes, and are from six mice in each group.
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chain reaction analysis of kidney samples showed that gene
expression of the inflammatory chemokines CCL2/MCP-1,
CCL3/MIP1a, CCL4/MIP1b, and CCL5/RANTES was simi-
larly upregulated in kidneys from spontaneously and IFNa-
treated, nephritic NZB/W mice compared with that in young
mice (Figure 8). However, the expression of two chemokine
genes differed between IFNa-treated and spontaneously
diseased NZB/W mice. Expression of the IFN-inducible
chemokine CXCL10/IP-10 was increased by 43-fold
(Po0.001) in IFNa-treated mice compared with that in
spontaneously nephritic mice. In the latter, CXCL10/IP-10
gene expression was slightly but not significantly increased
compared with that in young pre-autoimmune controls. In
contrast, CXCL13/BLC gene expression was markedly
increased in spontaneously nephritic mice (by 7-fold;
Po104), compared to pre-autoimmune, control mice,
whereas the increase was limited, though significantly
(Po0.005), in IFNa-treated mice (Figure 8). Thus, the
kidney from chronically and acutely nephritic mice
shows both common and differential expressions of chemo-
kine genes.
Migration of spleen cells to chemokines in spontaneously
and IFNa-treated, nephritic NZB/W mice
To know whether the absence of inflammatory infiltrates in
the kidney of IFNa-treated mice lies in the defects of
leukocytes to migrate toward chemokines, we compared such
migration, in vitro, on splenocytes from both chronic and
acute models of lupus nephritis. Leukocytes from IFNa-
induced, nephritic mice migrated less efficiently toward
several inflammatory chemokines than leukocytes form
spontaneously nephritic mice. Indeed, ‘IFNa’ T cells showed
depressed chemotaxis to MCP-1 and RANTES (Po0.01 and
Po0.05 vs spontaneous nephritis, respectively) and a trend
to diminished chemotaxis to MIP1a and MIP1b (Figure 9).
In regard to the expression of renal chemokines described
above, migration of ‘IFNa’ T cells toward IP-10 was
depressed when compared with the marked increased
sensitivity of T cells from spontaneously nephritic mice
(Po0.01), while chemotaxis of B cells to BLC was similarly
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Figure 8 | Reverse transcription-polymerase chain reaction analysis of renal chemokines in spontaneously and IFNa-treated, nephritic
NZB/W mice. Real-time reverse transcription-polymerase chain reaction was performed using total renal RNA of pre-autoimmune (white),
spontaneously nephritic (gray), and IFNa-treated nephritic (black) NZB/W mice. Levels of mRNA expression for the indicated chemokines
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Figure 9 | Migration of spleen cells to chemokines in
spontaneously and IFNa-treated, nephritic NZB/W mice. In vitro
migration of T and B lymphocytes in response to various chemokines
was tested. Results are expressed as the percentage of the total input
cells that had migrated into the bottom chamber. For each value, we
subtracted spontaneous migration of splenocytes in the mock
control. Data are the mean7s.d. from 4–8 individual mice in each
group. *Po0.05; **Po0.01; and ***Po0.005.
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increased in both the models. Thus, both depressed renal
chemokine expression (in particular, BLC) and leukocytic
chemotaxis impairment (in particular to IP-10) may
contribute to the paucity of interstitial inflammatory
infiltration in acute IFNa-induced nephritis.
DISCUSSION
The severity of interstitial inflammation in lupus nephritis
correlates with the degree of renal insufficiency and predicts
progressive deterioration of renal function.2,6–9 Little is
known however about both the origin of mononuclear
infiltrates and the factors that favor such infiltration. Here,
we show in the NZB/W mouse model of lupus that B, T
lymphocytes and myeloid cells from splenic origin can
migrate to the kidney, and that this migration operates in
restricted conditions that involve abnormalities in both
leukocytes and the kidney.
Our in vivo transfer experiments showed that spleen
leukocytes from spontaneously nephritic NZB/W have a
trend to migrate into non-inflamed kidney of young NZB/W,
an ability that is further potentiated by the inflamed state of
the recipient kidney. Therefore, combined leukocyte and
kidney abnormalities are needed for interstitial infiltration.
All major cell populations of the spleen from chronically
diseased mice showed an exclusive ability to migrate to the
kidney and not to other target organs. This contrasts with
peritoneal lupus B1 B cells that showed defective homing to
the peritoneal cavity and preferential recruitment in several
target organs of diseased NZB/W mice, including the
kidney.22,23 Using two models of lupus nephritis, one with
chronic and the other with acute (IFNa induced) disease, we
found that the latter differed from the former by the virtual
absence of interstitial inflammatory infiltration. We took
advantage of these models to further delineate kidney and/or
leukocyte abnormalities that promote or hamper interstitial
leukocyte infiltration.
The absence of leukocyte infiltration in the ‘acute’, IFNa-
induced form of nephritis could result from particular
features of the interstitial kidney compartment and/or
circulating leukocytes. At the kidney level, our data show
that leukocytes from old, proteinuric NZB/W mice are able to
migrate in vivo into the kidney of proteinuric IFNa-treated
mice, suggesting that the kidneys of both ‘chronic’ and ‘acute’
models of lupus nephritis share some common features that
permit leukocyte migration in both instances. Expression of
inflammatory chemokines (ie, CCL2/MCP-1, CCL3/MIP1a,
CCL4/MIP1b, and CCL5/RANTES) is increased not only in
spontaneously nephritic NZB/W mice, a result in accordance
with previous reports in MRL lpr and NZB/W models of
murine lupus nephritis,24–27 but also in the kidney of IFNa-
treated mice with acute nephritis. In human and murine
lupus nephritis, overexpression of CCL2, CCL3, CCL4, and
CCL5 is associated to macrophage and T-cell infiltration.20,21
Similar overexpression of these chemokines in the kidney of
spontaneously and IFNa-induced nephritic mice might
explain the ability of monocytes and T cells from sponta-
neously diseased mice to migrate in vivo into ‘IFNa’ kidneys.
Transfer experiments also showed the ability of B cells from
spontaneously diseased mice to migrate in vivo into ‘IFNa’
kidneys. We found however that gene expression of BLC/
CXCL13, a major B-cell attractant, was lower in IFNa
kidneys than in kidneys of spontaneously nephritic mice in
which BLC/CXCL13 gene expression was markedly increased
compared with pre-autoimmune mice, as previously re-
ported.25,28 This suggests that either the levels of CXCL13/
BLC in the ‘IFNa’ kidney are sufficient to attract B
lymphocytes from spontaneously nephritic mice and/or that
B cells are attracted by other kidney-expressed chemokines
such as CXCL10/IP-10, whose corresponding receptor
CXCR3 is expressed on activated normal B cells29 and on
most B cells from lupus patients.30 The kidney of IFNa-
treated mice strongly expressed the CXCL10/IP-10 gene,
supporting the above hypothesis. Thus, differences in a very
restricted set of renal chemokines (ie, CXCL10/IP-10 and
BLC/CXCL13) exist between the chronic and acute model of
lupus nephritis.
At the leukocyte level, our transfer experiments showed
that leukocytes from acutely diseased mice failed to migrate
in vivo into chronically inflamed kidney. This result is
corroborated by in vitro migration experiments in which
splenic T cells from IFNa-treated mice show poor, if any,
migration toward major T-cell attractant chemokines includ-
ing CCL2/MCP-1, CCL3/MIP1a, CCL4/MIP1b, CCL5/
RANTES, and, to lesser extent, CXCL10/IP-10. Whether this
is due to lack/internalization of the corresponding chemo-
kine receptors and/or defects in signal transduction is
unknown at present. Chemotaxis of ‘IFNa’ splenic B cells
to CXCL13/BLC was upregulated as in the spontaneous
model, suggesting that defective ‘IFNa’ B-cell migration
in vivo may be due to insufficient expression of the
chemokine at the kidney level.
Therefore, various mechanisms explain why acutely,
IFNa-treated, nephritic mice show very little, if any,
leukocyte infiltration in their kidney. At the kidney level,
the little expression of CXCL13/BLC may not be sufficient to
attract B lymphocytes, although these cells express a normal
chemotactic response to the chemokine. Indeed, aberrant
expression of CXCL13 is sufficient to induce the formation of
ectopic lymphoid tissue in non-lymphoid organs,31 and may
be responsible for the renal recruitment of B cells and
activated T cells that express the CXCL13 receptor, CXCR5,
leading to renal inflammation in spontaneously nephritic
NZB/W mice28 and in patients with acute interstitial
nephritis.32 On the other hand, the poor or no chemotactic
response of ‘IFNa’ T cells to inflammatory T-cell attractant
chemokines might explain the lack of T-cell infiltration in
these mice. Thus, combined abnormalities in both kidney-
expressed chemokines and leukocyte chemotactic activity
may concur to the development or, alternatively, the absence
of interstitial inflammation.
The use of our ‘acute’ model of lupus will be highly
informative to dissect the inflammation mechanisms
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involved in glomeruli against interstitial damages. Acute
pathological changes induced by IFNa, with prominent
glomerular damages, might be close to those observed during
‘flares’ of lupus nephritis in human, with reversion following
aggressive immunosuppressive treatments, whereas changes
in the ‘chronic’ form would be more representative of lesions
leading to progressive fibrosis in human lupus nephritis.
Thus, delineation of the immune pathologic chemokine/
chemokine receptors network in both the ‘acute’ and
‘chronic’ models of lupus will be important to determine
whether similar chemokine/chemokine receptor antagonists
should be tested depending on the stage of nephritis and on
the final purpose of the treatment, to cure a flare or to
prevent fibrosis.
MATERIALS AND METHODS
Mice
Female (NZBNZW) F1 (NZB/W) mice were bred in our
conventional animal facility. Age-matched female BALB/c mice were
used as controls. NZB/W mice (7- to 9-months old) with moderate to
severe proteinuria (see below) were considered aged, while 7- to 10-
week-old mice without proteinuria were considered young.
Proteinuria
Urine was tested for proteinuria using Multistix 8 SG (Bayer
Diagnostics, Puteaux, France) on a 0–4þ scale, corresponding to
the following approximate protein concentrations: 0, negative or
trace; 1þ , 30 mg/dl; 2þ , 100 mg/dl; 3þ , 300 mg/dl; and 4þ ,
2000 mg/dl. Mice were considered to have nephritis if two
consecutive urine samples scored 3þ .
IFNa treatment
The recombinant adenovector (Adv) containing the mIFNa
(AdCMVmIFNa5) and the control (AdvCMV null) were obtained
from Qbiogene (Illkirch, France). NZB/W mice were treated at 10
weeks of age with a single intravenous injection of 1 1010 IFNa
Adv particles in the retro-orbital plexus.18 Control NZB/W mice
received the same amount of control Adv particles. A total of 3–4
weeks following initiation of IFNa Adv treatment, mice became
proteinuric with scores of 3þ –4þ .18
Cell labeling and adoptive transfer
Splenocytes were labeled using the cell tracker orange CMTMR or
Calcein AM (Molecular Probes, Strasbourg, France). For each
adoptive transfer, spleen cells were labeled in 10 mM of cell tracker for
30 min at 371C. A 200-ml volume of 2.5 107/ml cells was labeled
with Calcein, while another group of cells were labeled with
CMTMR. Equal numbers of each labeled cells were co-injected
intravenous into syngeneic mice, which were killed 18 h after
injection for quantifying cell migration by flow cytometry.
Flow cytometry studies
Single-cell preparations from recipient mice were stained with
specific antibodies (Abs) (all from BD Pharmingen, Le Pont de
Chaix, France) and analyzed by four-color flow cytometry.
Antibodies were PerCP-Cy5,5-labeled rat anti-CD11b, PerCP-
Cy5,5-labeled hamster anti-CD3, allophycocyanin (APC)-conju-
gated rat anti-CD19, and the corresponding isotype-matched
control Abs. The frequency of cells that had migrated into the
recipient tissues is expressed as the numbers of fluorescently labeled
cells for 106 lymphocytes counted in the lymphocyte gate. Activation
of B, T lymphocytes, and macrophages was examined using the
following Abs: fluorescein isothiocyanate-labeled, rat anti-CD25, rat
anti-CD86, biotin-labeled, hamster anti-CD69, and rat anti-CD138,
and the corresponding isotype-matched control Abs.
Immunohistochemistry
Cryostat sections (5-mm thick) of kidney were fixed in ice-cold
acetone, air dried, hydrated with phosphate-buffered saline, blocked
with the avidin–biotin kit (Vector Laboratories, Burlingame, CA,
USA), followed by treatment with normal rabbit serum (or goat
serum for anti-CD3 staining), and were then stained with anti-B220,
anti-CD11b or anti-CD3 monoclonal antibodies (all from BD
Pharmingen) for 1 h at room temperature. Detection of bound Abs
was performed using the rat IgG Vectastain Elite ABC kit (Vector
Laboratories), except for CD3 staining which was revealed using
biotinylated goat anti-hamster Abs (Jackson) followed by perox-
idase-conjugated streptavidin (Roche Diagnostics, Meylan, France).
Color was developed with 3,30-diaminobenzidine (Vector Labora-
tories) and samples counterstained with hematoxylin.
Reverse transcription polymerase chain reaction analysis of
chemokine expression
Total RNA was isolated from cryosections using RNeasy mini kit
(Qiagen, Courtaboeuf, France). mRNAs were extracted using
the oligotex kit (Qiagen), reverse transcribed using SuperScript II
RT (Invitrogen, Cergy Pontoise, France), and amplified with
specific oligonucleotide primers (CCL2: sense 50-AGGTCCCTGTC
ATGCTCTG-30, antisense, 50-TCTGGACCCATTCCTTCTTG-30; C
CL3: sense 50-GCCCTTGCTGTTCTTCTCTGT-30, antisense, 50-GG
CATTCAGTTCCAGGTCAGT-30; CCL4: sense 50-CCCACTTCC
TGCTGTT-TCTC-30, antisense, 50-GAGGAGGCCTCTCCTGAA
GT-30; CCL5: sense 50-CACCTGCCTC-ACCATATGGC-30, antisense,
50-GGCGGTTCCTTCGAGTGACA-30; CXCL10: sense 50-GC-TG
CCGTCATTTTCTGC-30, antisense, 50-TCTCACTGGCCCGTCAT
C-30; CXCL13: sense 50-CATAGATCGGATTCAAGTTACGCC-30,
antisense, 50-TCTTGGTCCAGATCACAACTTCA-30).
In vitro migration assays
Migration of leukocytes was evaluated in duplicates using 96-well
Transwell inserts (5 mm pore size; Corning Costar, Avon, France). In
brief, spleen cells were first labeled with fluorescein isothiocyanate-
labeled anti-CD3, phycoerythrin-labeled anti-B220, and APC-
labeled CD11b monoclonal antibodies (BD Pharmingen). After
washing, cells were resuspended into prewarmed migration medium
(RPMI 1640, 20 mM Hepes, 1% bovine serum albumin), and 150ml
of the cell suspension (input of 2 106 cells) were added to the
upper chamber of the insert. The lower chamber contained
prewarmed migration medium with or without 500 ng/ml of the
indicated recombinant mouse chemokine (R&D Systems, Lille,
France). Cells that had migrated 3 h later into the lower chamber
were counted by flow cytometry.
Statistical analysis
Statistical analysis was performed using the non-parametric
Mann–Whitney U-test.
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